CTLA4 and neoplasm: Indeed, an anti-PD-L1 or anti-CTLA-4 antibody remarkably reduced tumor volume in mice bearing Ythdf1-KO B16/F10 cells compared with an immunoglobulin G (IgG) antibody (Fig. 6C).